Am J Transplant, Volume 21, Suppl 3 Archives - Page 117 of 139 - ATC Abstracts

2021 American Transplant Congress
Long-Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients
J. Leventhal¹, J. Galvin², J. Mathew¹, L. Gallon¹, D. Belshe¹, M. Gibson¹, K. Ravindra³, M. Horwitz³, S. Ildstad⁴
¹Northwestern University, Comprehensive Transplant Center, Chicago, IL, ²Northwestern University, Chicago, IL, ³Duke Medical Center, Durham, NC, ⁴University of Louisville, Llouisville, KY
*Purpose: 37 subjects were transplanted in a phase 2 protocol based upon tolerogenic CD8+/TCR-facilitating cells (FCR001) to induce tolerance in recipients of living donor renal…
2021 American Transplant Congress
Intravenous Immunoglobulin in Heart Transplant Recipients with Hypogammaglobulinemia and Infection
J. Hoang, D. Nguyen, E. Graviss, M. Moaddab, A. Guha, J. Krisl
Houston Methodist Hospital, Houston, TX
*Purpose: Hypogammaglobulinemia (HGG) is a complication of solid organ transplantation which has been associated with increased risk of infections. HGG is commonly defined as a…
2021 American Transplant Congress
Cryptococcosis in Renal Transplant Recipients —An Analysis of United States Renal Data System Data
M. E. Cervera-Hernandez, H. A. Yoon, L. Pirofski, V. Hemmige
Montefiore Medical Center, Bronx, NY
*Purpose: Solid organ transplant recipients are at increased risk for cryptococcosis, which is known to decrease their survival. Adherence to recommended management strategies and outcomes…
2021 American Transplant Congress
Breakthrough Cytomegalovirus DNAemia in High vs Intermediate Risk Heart Transplant Recipients
G. Huang¹, O. E. Beaird¹, M. Davis², M. Carlson¹, S. Chang¹, P. Gaynor¹, A. Fan², M. Deng³, A. Multani¹, A. Nsair³, J. Schaenman¹
¹Infectious Diseases, UCLA, Los Angeles, CA, ²Pharmacy, UCLA, Los Angeles, CA, ³Cardiology, UCLA, Los Angeles, CA
*Purpose: Cytomegalovirus (CMV) is one of the most common infections after transplantation and continues to cause significant morbidity and mortality despite prophylaxis and screening strategies.…
2021 American Transplant Congress
Covid vs Non Covid Pneumonia in Kidney Transplant Recipients
R. Prashar, N. Khoury, P. Shrivastava, S. Yeddula, T. Kitajima, E. Ulrich, M. Ramesh, A. Patel, S. Nagai, M. Samaniego-Picota
Henry Ford Hospital, Detroit, MI
*Purpose: Compare clinical characteristics and outcomes in kidney transplant recipients (KTRs) hospitalized with COVID vs Non COVID Pneumonia.*Methods: This is a retrospective case‐control study examining…
2021 American Transplant Congress
Changes in Cytomegalovirus Specific T Cell Immunity With Immunomodulation in Serodiscordant High Risk Transplant Recipients
T. Tinkham, C. Song, R. Winstead, I. Yakubu, A. Brown, S. Sterling, G. Gupta, D. Kumar
Virginia Commonwealth University Health, Richmond, VA
*Purpose: Cytomegalovirus (CMV) infections cause significant morbidity and mortality among all solid organ transplant recipients. CMV discordant (D+/R-) recipients are at higher risk of developing…
2021 American Transplant Congress
Efficacy and Safety of a High Dose Ganciclovir Dosing Strategy in Kidney and Pancreas Transplant Recipients
M. Jorgenson¹, J. Descourouez¹, G. Leverson², C. Saddler², J. Smith², D. Mandelbrot², J. Odorico²
¹UW Health, Madison, WI, ²UW School of Medicine and Public Health, Madison, WI
*Purpose: Evaluate efficacy and safety of a strategy utilizing high dose ganciclovir in kidney and pancreas transplant recipients requiring hospital admission for CMV infection.*Methods: Adult…
2021 American Transplant Congress
Cytomegalovirus Infection Among Adult Kidney Transplant Recipients: Findings From the USRDS-medicare Linked Database Study
A. Raval¹, M. Ganz², S. Alam², Y. Tang¹, C. Santos³
¹Merck & Co., Inc., Rahway, NJ, ²Evidera-PPD, Waltham, MA, ³Rush University Medical Center, Chicago, IL
*Purpose: Cytomegalovirus infection (CMVi) is a frequent complication and significant cause of morbidity and mortality after kidney transplantation (KT). However, there are limited recent national…
2021 American Transplant Congress
Black Patients Do Not Have Worse Short-Term Outcomes After Receiving High KDPI (>85%) Kidneys
K. Atiemo¹, S. Guisti¹, K. Guo², T. Amankonah¹, A. Vijay¹, A. Paramesh¹, M. Killackey¹, H. Jeon¹, L. Zhao², D. Ladner²
¹Tulane University, New Orleans, LA, ²Northwestern University, Chicago, IL
*Purpose: Some studies have suggested Black kidney transplant recipients have an increased incidence of graft failure and worse survival. We examined whether this finding is…
2021 American Transplant Congress
Simulation Model for Cytomegalovirus Matching in Deceased Donor Kidney Allocation System in the U.S.
B. Tanriover¹, V. K. Ariyamuthu¹, T. Zangeneh², M. M. Al Obaidi², Y. Ulukus³, M. A. Ergun³, B. Sandikci⁴
¹Department of Medicine / Nephrology, University of Arizona, COM Tucson, Tucson, AZ, ²Department of Medicine / Infectious Disease, University of Arizona, COM Tucson, Tucson, AZ, ³Operations Management, Istanbul Technical University, Istanbul, Turkey, ⁴Operations Management, University of Chicago, Chicago, IL
*Purpose: The prevalence of positive and negative cytomegalovirus (CMV) serology among transplant recipients and donors are approximately 60-65% and 30-35%, respectively. CMV mismatch, donor-positive/recipient-negative status…